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Hemodialysis prescription and delivery in a metropolitan community.
The National Cooperative Dialysis Study attempted to determine
adequacy of hemodialysis based on kinetic modeling of urea. Based on
this study, it has been recommended that a dimensionless term quan-
titating the amount of dialysis delivered (KT/V) be greater than 1.0 to
avoid adverse outcomes. With the declining duration of dialysis treat-
ments in the United States, there has been concern that a significant
proportion of patients may be receiving inadequate therapy. The
purpose of this study was to survey hemodialysis practices and treat-
ment outcomes in our metropolitan area. Sixteen area nephrologists
volunteered to study their outpatient hemodialysis patients (N = 617).
Demographic data and urea kinetic modeling results were then analyzed
at the lead center. The mean length of dialysis was 3.2 0.4 (SD) hours
with dialysis blood flow rates of 333 74 mI/mm. The mean KT/V was
1.03 0.25 with nearly half of patients failing to attain a KT/V of 1.0.
In 55% of patients the reason for a low KT/V was the prescription of an
insufficient amount of dialysis treatment. In the remainder, insufficient
delivery of prescribed dialysis contributed to the low KT/V. Only 1 of
33 patients undergoing dialysis twice a week achieved the recom-
mended quantity of treatment on a weekly basis. Patients undergoing
dialysis in non-profit units had a higher KT/V than those treated in
proprietary units (1.1 0.26 vs. 0.92 0.22, P < 0.001). In addition,
patients dialyzed in units that performed urea kinetic modeling on all or
selected patients had a higher KT/V compared to those in units where
urea kinetics were not done (1.12 0.25 vs. 0.95 0.23, P < 0.001). If
these findings reflect practices elsewhere in the United States, many
hemodialysis patients fail to receive the current recommended quantity
of treatment.
In the mid 1970s, the National Institute of Health sponsored
a comprehensive multi-center study called the National Coop-
erative Dialysis Study (NCDS) to evaluate adequacy of hemo-
dialysis. These investigations were based on kinetic modeling of
urea removal during dialysis treatments and urea generation
between treatments (urea kinetic modeling) [1]. Patients were
randomized into four groups: I. long dialysis duration, low
BUN; II. long dialysis duration, high BUN; III. short dialysis
duration, low BUN; and IV. short dialysis duration, high BUN.
It was found that patients in the groups with high levels of BUN
encountered more morbid events such as medical withdrawal
and hospitalizations [2]. The data of the NCDS was subse-
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quently reanalyzed by Gotch and Sargent [3]. Using the dimen-
sionless term KT/V (where K = dialyzer clearance of urea in
ml/min, T = dialysis time in minutes, and V = volume of
distribution of urea in ml) to quantify the dialysis procedure,
they found that those patients receiving a KT/V of 0.8 were
fourfold more likely to be hospitalized or medically withdrawn
from the study compared to those with a KT/V 0.9. Patients
with a protein catabolic rate (pcr) of 0.8 g/kg/day were also at
higher risk for morbid events. (Under steady state conditions,
pcr is equivalent to the dietary protein intake.) They concluded
that "a fully adequate dialysis prescription is provided with pcr
= 1.0 and KT/V = 1.0" and that more intensive dialysis was
unlikely to improve the clinical outcome [3]. Analyzing the
same data, Keshaviah and Collins [4] determined that optimal
clinical outcomes would occur with a KT/V as high as 1.3. This
controversy has been recently reviewed by Hakim [5] who
recommended a KT/V of at least 1.2 and a dietary protein intake
of 1 g/kg/day.
There has been a general trend in the United States to
decrease treatment times from approximately 15 to 18 hours per
week in the 1970s to 7.5 to 10.5 hours per week, as is now
commonly practiced. The reasons for this include the availabil-
ity of more efficient technology, economic incentives, and
pressure from patients. Concerns that shortened dialysis times
may have adverse consequences were voiced at the Morbidity,
Mortality, and Prescription of Dialysis Symposium held in
September, 1989. Hull and Parker [6] noted that the gross
mortality rate for dialysis patients in the United States is greater
than that of most European countries and Japan, areas that
generally practice longer dialysis. The higher mortality rates
were also present when data were adjusted for the presence of
diabetes and age [7]. Of further concern was the trend for
worsening gross mortality rates in the United States starting in
1985 [6]. Although the data could not rule out a role for
co-morbid variables, it was also conjectured that inadequate
delivery of dialysis treatments was a significant factor. Gotch et
a! [8] calculated that 25% of transient hemodialysis patients
treated at their unit were prescribed treatments with a KT/V of
0.8 and that only 2% of patients had undergone some analysis
of the quantity of dialysis actually delivered. Sargent [9], as part
of a marketing program for urea kinetics, found that 44% of
dialysis units had less than 50% of treatments delivered as
expected. Remarkably, there is no available information that
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Fig. 1. Number of patients nndergoing hemodialysis for a given time
(h), The mean length of dialysis treatments was 3.2 0.4 hours.
describes dialysis prescription and delivery outcome in the
United States. To that end the St. Louis Nephrology Study
Group, an informal organization of private and academic neph-
rologists, was formed to address this issue. The assumption was
that the dialysis practices in this large metropolitan community
was reflective of the United States.
A total of 16 area nephrologists practicing at 11 adult outpa-
tient hemodialysis units volunteered to participate in the study.
Four of the dialysis units were non-profit, four were propri-
etary, and three were affiliated with a medical school. They
accounted for 44, 20, and 36%, respectively, of the hemodialy-
sis patients studied (total = 617 patients). The patients studied
represented approximately 75% of the total population of pa-
tients undergoing outpatient hemodialysis in the metropolitan
St. Louis area. Two dialysis units routinely performed urea
kinetic modeling, two did modeling on selected patients, and
seven had no previous experience with quantitation of dialysis
treatments. No unit performed high flux dialysis (defined as
using dialyzers with an ultrafiltration coefficient of >15 mllhr,
torr). Seven units reprocessed patients' dialyzers for repetitive
uses. The dialysis units obtained pre- and post-dialysis BUN
levels following the longest interdialytic interval and a pre-
dialysis BUN at the next treatment. If a patient's measured
urine output was more than 200 mI/day, urine was collected
between the two treatments for the determination of urea. The
results of the urea measurements and selected patient charac-
teristics were sent to the lead center for collation, calculation of
urea kinetics, and statistical analysis. The survey started in
December, 1989, and ended September, 1990. One urea kinetic
modeling was performed for each patient.
There were 291 males and 326 females enrolled in the study.
The mean age was 60.4 15.1 (SD) years. The duration of
dialysis was 43.3 42.8 months with 470 patients undergoing
dialysis for greater than 12 months. The mean weight was 69.0
17.4 Kg and body surface area was 1.75 0.23 m2.
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Fig. 2. The number of patients undergoing hemodialysis at a given
blood flow, Q5. The mean Qb was 333 74 mI/mm.
Calculations
The calculation of KT/V was according to the formula [10]:
KT/V = 1.16 — ln(1 — AC/C01) (1)
where AC = change in BUN during dialysis (mg/dl), and CO1 =
pre-dialysis BUN concentration (mg/dl).
The normalized protein catabolic rate (g/kg/day) was calcu-
lated according to the formula:
0.58 9.35 . (0 + 1.2)pcr= V (2)
where V = volume of distribution of urea (ml) estimated
according to body surface area [11] and 0 = urea generation
rate (mg/mm) calculated from the formula:
(CO2—Ct) 10 V
where CO2 = pre-dialysis midweek BUN and Ct = post-dialysis
BUN and t = time (mm) between dialysis treatments. Interdi-
alytic urine urea excretion rates were obtained in 19 patients.
These results were incorporated into the calculations.
The effective clearance (K effective) was calculated accord-
ing to the formula:
V
K effective 1.16 — In (1 — AC/CO1) (4)
where T = duration (mm) of the dialysis treatment.
Statistics
Results are expressed as mean SD. Statistical analyses
utilized Student's t-test for normally distributed data, Wilcoxon
rank sum for non-parametric data and linear regression analy-
sis. Stepwise linear regression was performed using SAS,
Release 6.06 (SAS Institute Inc., Cary, North Carolina, USA).
Results
The number of patients dialyzing for a given time is shown in
Figure 1. The mean length of dialysis treatments was 3.2 0.4
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Fig. 4. The cumulative per cent of patients receiving a hemodialysis
treatment delivering less than a given KTIV. The mean and median was
1.03 with almost half of patients not attaining a KT/V of 1.0.
Table 1. Comparison of twice-per-week and three-times-per-week
•••• I1
H H H H H H H H H
0 0.5 1.0
E
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2xlweek 3x/week P value
T hr 3.2 0.4 3.2 0.5 NS
Qb mi/mm 308 52 335 75 NS
Wt kg 66 17 69 17 NS
Age yr 67 10 60 16 <0.01
KT/V 1.09 0.27 1.03 0.29 NS
KT/V per week 2.19 0.53 3.08 0.76 <0.001
pcrglkg/day 0.82 0.19 0.92 0.24 <0.02
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Fig. 3. A composite of KT/V, blood flow (Qb), and time (T)for each of
the II dialysis Units participating in the study. The horizontal dotted
line represents mean values of all patients. See text for details.
hours. The results of the blood flows (Qb) prescribed to the
patients are shown in Figure 2. The largest group had a Qb of
300 mI/mm, The second and third largest groups were treated
with a Qb of400 and 250 mI/mm, respectively. The mean Qb was
333 74 mI/mm. The dialysate flow rate was 500 mI/mm in all
units except unit I where a dialysate flow rate of 800 mI/mm was
used in 40 percent of patients.
A composite of the mean KT/V, Qb and time for each of the
11 dialysis units is shown in Figure 3. The horizontal dotted line
represents mean values of all patients. There was a large
variability of time and Qb in relation to the mean KT/V for each
unit. For example Unit A dialyzed at a high mean Qb of 400
mI/mm and for a relatively long time of 3,4 hours. However, the
KT/V was only slightly above the mean for all the patients
surveyed. Unit I dialyzed at the same Qb but for a markedly
lower mean time of 2.8 hours. This unit had the highest KT/V.
The difference, in part, was due to the use of more efficient
dialyzers by Unit I (data not shown). In addition, it was later
T denotes time, Qb blood flow rate, Wt weight, pcr protein catabolic
rate. Plus-minus values are mean SD. Statistical significance deter-
mined by Wilcoxon rank sum.
determined that the speed of the blood pumps in unit A was
inaccurately calibrated. Unit F dialyzed for a relatively long
time yet had the lowest Qb and the lowest mean KT/V. Patients
undergoing dialysis in units that performed urea kinetic model-
ing on all or selected patients had a higher KT/V compared to
those in units where urea kinetics were not done (1.12 0.25 vs
0.95 0.23, P < 0.001). In addition, patients undergoing
dialysis in proprietary units had a lower KT/V than those
treated in non-profit units (0.92 0.22 vs. 1.1 0.26, P <
0.001). Only one proprietary unit had experience with urea
kinetic modeling. Surprisingly, those patients dialyzed with
reprocessed dialyzers had higher values of KT/V than those not
dialyzing with reprocessed dialyzers (1.06 0.27 vs. 1.0 0.24,
P < 0.01).
The cumulative percent of patients receiving a treatment less
than a given KT/V is shown in Figure 4. The KT/V was 1.03
0.25 with almost half of patients receiving a KT/V of less than
1.0. Nearly 20% of patients had KT/V of less than 0.8.
The results of the 33 patients (30 of whom were anuric)
undergoing dialysis twice a week was compared to those
receiving dialysis three times a week (Table 1). The time of each
treatment was the same for each group (3.2 hours). Surpris-
ingly, the Qb was slightly lower for the group receiving dialysis
twice a week (308 vs. 335 mI/mm, respectively). Although the
KT/V was comparable in the two groups, the quantity of
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Fig. 5. The relationship of protein catabolic rate (pcr) to KT/V. There was a positive correlation (P < 0.01) but considerable variability.
dialysis delivered on a weekly basis to patients dialyzing twice
a week was considerably lower. The first of the week, pre-
dialysis BUN levels were 79 12 mg/dl in the twice-per-week
patients and 74 19 mg/dl in patients treated three times per
week (P = NS). This similarity, despite lower weekly clear-
ances of BUN, was due to the lower protein intake (assessed by
per) by the twice-per-week dialysis patients. Only one of the 33
patients attained a weekly KT/V (defined as number of treat-
ments per week times KT/V) of greater than 3.0.
The per was compared to the KT/V (Fig. 5). There was a
significant correlation (P C 0.01) but substantial variability.
There was no correlation of age with per or KT/V (data not
shown).
Stepwise linear regression analysis was performed to deter-
mine the relative importance of K effective, V, T, Qb, per, and
duration of dialysis in determining KT/V in all patients. K
effective appeared to be the most important variable (partial
= 0.44) followed by V and T (partial r2 = 0.28 and 0.22,
respectively). The other factors were relatively unimportant
(partial r2 C 0.002),
The expected clearance of a dialyzer (K expected) at the
prescribed blood flow was calculated for each patient based on
the manufacturers' published clearances. The ratio of the K
effective (equation 4) to the K expected was plotted against
KT/V and a strong correlation was found (Fig. 6). This data was
further analyzed to gain insights into the causes of a KT/V
under 1.0. In 151 patients the effective clearance was near the
expected clearance (arbitrarily defined as K effective/K ex-
pected > 0.8). The explanation for the low KT/V in this group
would be under prescription of dialysis. One hundred and
twenty-five patients had a low KT/V and lower than anticipated
effective clearances. In these patients insufficient delivery of
the prescribed dialysis contributed to the low KT/V.
Discussion
To our knowledge, there have been no previous reports of
hemodialysis prescription patterns and quantitative outcomes
in a general population setting. That nearly half the patients did
not attain a KT/V of 1.0 suggests that a considerable proportion
may be receiving insufficient amounts of therapy. This was
particularly evident in those dialyzing twice a week. In this
group only 1 of 33 patients achieved the recommended weekly
KT/V of 3.0.
In the majority of patients, the cause of the low KT/V was the
prescription of insufficient dialyzer clearance and dialysis time
to attain a KT/V of 1.0. In the remaining 45% of patients the
quantity of dialysis actually delivered was less than 80% of that
predicted. The possible reasons for this include dialyzer mal-
function [12], recirculation within the vascular access [13],
blood or dialysate flow rates less than those prescribed, and
premature cessation of the dialysis treatment. The relative
importance of each of these factors in contributing to the low
KT/V could not be assessed in this study.
The correlation of per with KT/V may be explained in two
ways. Lindsay and Spanner [14] studied the effect of either
increasing or decreasing KT/V in 20 hemodialysis patients. In
all, the change in per correlated with the change in KT/V. Thus,
in healthy dialysis patients, changes in the dialysis treatment
r = 0.31
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Fig. 6. The relationships of KTIV and the ratio of the effective clearance (K effective) and expected clearance (K expected). A strong correlation
was found (P < 0.01). See text for details.
appear to affect appetite. In addition, many nephrologists
prescribe dialysis treatments determined by the results of
mid-week BUN levels. A low dietary protein intake would
lower these levels leading to a temptation to reduce the inten-
sity of dialysis. Appetite could then be further reduced, setting
up a vicious cycle. Lowrie and Lew [151 have recently shown in
chronic hemodialysis patients that simple laboratory values
suggestive of malnutrition (such as, low BUN, low albumin,
creatinine, etc.) were highly associated with probability of
death.
This study did not address the important question of whether
patients receiving a KT/V < 1.0 suffered adverse clinical
outcomes. However, the results of the NCDS study as analyzed
by Gotch and Sargent [31 would suggest that a significant
proportion of the patients was at risk for morbid events and
hospitalization. Recently, Held et al [16] reported an increased
three year mortality in 600 patients undergoing hemodialysis
with a treatment duration of less than 3.5 hours. Because none
of the units studied performed high efficiency or high flux
dialysis during the study period (1984 to 1987), the authors
suggested that the reduction in dialysis duration reflected a
reduction in KT/V. In the current study effective dialyzer
clearance had a more important impact on KT/V than time.
Several assumptions were used in this study. The first was
that urea kinetic modeling is of value in monitoring adequacy of
dialysis. This has recently been challenged [17]. However, to
date no other method of quantifying hemodialysis treatment has
proved to be superior or generally accepted. It was also
assumed that monitoring one dialysis treatment outcome re-
flects those of subsequent treatments. This cannot be proven or
refuted without further study. That only 19 patients (3%)
submitted urine for calculation of endogenous urea clearances
suggests that more may have had an adequate total KT/V if that
information were known. However, because the KT/V for
those 470 patients on dialysis over one year (and therefore
probably anuric) was only 1.06 0.25, the underestimation of
KT/V was probably small. In addition, duration of dialysis was
not independently related to KT/V.
The practical implication of this study is that empirical
prescription of hemodialysis treatments often results in a KT/V
< 1.0. Routine monitoring of the quantity of dialysis delivered
to each patient coupled with an aggressive response to poor
outcomes should improve this situation. If the effective clear-
ance is close to that expected in the face of a low KT/V, the
intensity of the dialysis treatment should be increased. This
may be achieved by increasing the duration of the dialysis
treatment, using a more efficient artificial kidney or increasing
blood flow. If, however, the effective clearance is substantially
less than that expected, a search into the cause should be
undertaken. Systematic evaluation of access recirculation, dia-
lyzer function, and dialysis procedures may give insight into the
causes(s) and lead to its correction.
We assumed that the dialysis practices in St. Louis are no
different than those in most other communities. Since all
2.0
1.6
1.2
0 0.4 0.8 1.2 1.6 2.0
Keffective/Kexpected
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participating nephrologists were board eligible in nephrology,
had training in a university setting, and voluntarily entered in
the study, this assumption is probably correct. Finally, assum-
ing that a KT/V of 1.0 represents the minimal amount of
treatment, this study suggests that almost half of the patients in
the United States may be receiving insufficient dialysis therapy.
Clearly, further studies and greater awareness of nephrologists
are needed.
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